Company intelligence / Profile preview
Wuhan Institute of Biological Products
Wuhan City – Jiangxia District/Zhengdian Gold Industrial Park/Wuchang District(original site), Hubei Province, Chinaen.wibp.com.cn ↗
- Ownership
- Private
- Employees
- ~1300
- Development stage
- Other
01
Overview
Wuhan Institute of Biological Products has developed and commercialized multiple vaccines including inactivated COVID‑19 vaccines (WIBP-CorV), quadrivalent influenza vaccines, and combination pediatric vaccines. Its COVID‑19 inactivated vaccine was among the first globally to receive clinical approval and has demonstrated robust safety and immunogenicity profiles in both adults and children. The company also develops monoclonal antibodies for infectious disease treatment.
- Therapeutic areas
- Infectious Diseases
- Modalities
- VaccineInactivated vaccineLive attenuated vaccineMonoclonal antibodyCombination vaccineProphylactic vaccine
- Industry
- Pharma
02
Drug pipeline
28 assets27 more assets in the full pipeline.
03
Partnerships
Beijing Institute of Biological Products/Sinopharm CNBG for joint development/manufacturing/distribution especially for COVID‑19 productsCollaborations with academic institutions such as Northwest Minzu University/Lanzhou Bailing Biotechnology on clinical trials
Beyond the preview
Go deeper on Wuhan Institute of Biological Products.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Wuhan Institute of Biological Products.